Fabtech Technologies IPO is a book-built issue worth ₹230.35 crores, consisting entirely of a fresh issue of 1.21 crore equity shares.
The IPO will open for public subscription on September 29, 2025, and will close on October 1, 2025. The basis of allotment is expected to be finalised on October 3, 2025, and the shares are proposed to be listed on both the BSE and NSE, with a tentative listing date of October 7, 2025.
The price band for the Fabtech Technologies IPO has been set between ₹181 and ₹191 per share. The lot size is 75 shares, which means retail investors need to invest a minimum of ₹14,325 to apply for one lot at the lower end of the price band.
Fabtech Technologies Ltd launched an Initial Public Offering (IPO) with a total issue size of ₹230.35 crore, entirely comprising a fresh issue of 1.21 crore equity shares. The IPO will open for subscription on September 29, 2025, and will close on October 1, 2025. The share allotment is expected to be finalised by October 3, 2025, with the company eyeing a stock market debut on the BSE and NSE on or around October 7, 2025. The price band for the IPO has been fixed at ₹181 to ₹191 per share.
The table below breaks down the Fabtech Technologies share allocation for different categories, highlighting the number of shares and their percentage of the total issue. However, the key focus remains on the quotas allocated to retail investors and HNIs, as they are the most relevant for individual investors.
| Investor Category | Shares | Maximum Allottees |
| QIB Shares Offered | 60,02,527 | NA |
| NII (HNI) Shares Offered | 18,00,758 (14.93%) | NA |
| Retail Shares Offered | 42,01,769 (34.84%) | 56,023 |
| Employee Shares Offered | 54,945 (0.46%) | NA |
| Total Shares Offered | 1,20,59,999 (100.00%) |
Data Source: NSE
| Category | Subscription (times) |
| Qualified Institutional Buyers | 1.34 |
| Non-Institutional Investors | 1.27 |
| Retail Individual Investors | 1.80 |
| Total shares | 1.49 |
Note: The subscription details are as of October 01, 2025, at 2:45 PM
Incorporated in 2018, Fabtech Technologies Ltd is a specialised biopharma engineering company focused on delivering innovative, turnkey solutions to the life sciences and pharmaceutical industries.
The company offers comprehensive end-to-end services covering the full project lifecycle—from concept and design to manufacturing, installation, and project management. Its core areas of expertise include cleanroom technology, HVAC systems, process equipment, and custom-engineered modular solutions tailored to meet global regulatory standards.
With a strong presence in both domestic and international markets, Fabtech Technologies supports pharmaceutical and biotech manufacturers by ensuring efficient, compliant, and scalable production environments.
Know more about IPO allotment status and check your application details online for the latest updates on share allocation.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Oct 1, 2025, 3:08 PM IST
Sachin Gupta
Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
